Therapeutic potential of genetically modified mesenchymal stem cells.
about
Therapy with un-engineered naïve rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinomaAdipocytes as a vehicle for ex vivo gene therapy: Novel replacement therapy for diabetes and other metabolic diseasesAdenoviral transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantationThe mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanismsGene delivery to human adult and embryonic cell-derived stem cells using biodegradable nanoparticulate polymeric vectors.Isolation of a stable subpopulation of mobilized dental pulp stem cells (MDPSCs) with high proliferation, migration, and regeneration potential is independent of age.Baculovirus transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation.Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastasesThe study of the intercellular trafficking of the fusion proteins of herpes simplex virus protein VP22Cytotherapy with naive rat umbilical cord matrix stem cells significantly attenuates growth of murine pancreatic cancer cells and increases survival in syngeneic mice.Differentiation of single cell derived human mesenchymal stem cells into cells with a neuronal phenotype: RNA and microRNA expression profile.Differential uptake of DNA-poly(ethylenimine) polyplexes in cells cultured on collagen and fibronectin surfaces.Therapeutic potential of genetically modified adult stem cells for osteopenia.Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasisGrowth factor regulation of proliferation and survival of multipotential stromal cells.Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition.Nontoxic genetic engineering of mesenchymal stem cells using serum-compatible pullulan-spermine/DNA anioplexes.Non-random tissue distribution of human naïve umbilical cord matrix stem cellsOptimization of multimodal imaging of mesenchymal stem cells using the human sodium iodide symporter for PET and Cerenkov luminescence imaging.Epithelial-Mesenchymal Transition in tumor microenvironment.Generation of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purificationHuman urokinase-type plasminogen activator gene-modified bone marrow-derived mesenchymal stem cells attenuate liver fibrosis in rats by down-regulating the Wnt signaling pathwayExtracellular acidity strengthens mesenchymal stem cells to promote melanoma progressionRevascularization of transplanted islets: can it be improved?Polyethylenimine600-β-cyclodextrin: a promising nanopolymer for nonviral gene delivery of primary mesenchymal stem cellsActivation of Wnt3a signaling promotes myogenic differentiation of mesenchymal stem cells in mdx mice.Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds.CYP1B1, a developmental gene with a potential role in glaucoma therapy.Exosomes derived from mesenchymal stem cells.Modification of mesenchymal stem cells for cardiac regeneration.Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer.Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer.Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.Natural ECM as biomaterial for scaffold based cardiac regeneration using adult bone marrow derived stem cells."Ins" and "Outs" of mesenchymal stem cell osteogenesis in regenerative medicine.Extracellular Vesicles Derived from Osteogenically Induced Human Bone Marrow Mesenchymal Stem Cells Can Modulate Lineage Commitment.Optimizing stem cells for cardiac repair: Current status and new frontiers in regenerative cardiologyNanotopography-mediated reverse uptake for siRNA delivery into neural stem cells to enhance neuronal differentiation.Mesenchymal stem cells promote pancreatic adenocarcinoma cells invasion by transforming growth factor-β1 induced epithelial-mesenchymal transition.
P2860
Q21261301-8CE5048F-FFD6-40F3-95D8-663E71EC8B2EQ27011815-125FD7FE-C707-4994-95F3-CAEE124A33A4Q27324639-E2C89649-E00E-47FB-A420-D6507860BFF5Q28568768-25194199-3707-447D-A764-AA6420CEFA27Q33398327-30FE7F7D-C5FC-4D19-9D9D-65053513CBAEQ33679751-95D7E1C7-545D-4718-99FC-DF179F9879A6Q33713464-35EA77FD-C163-43AC-8779-44759C300913Q33713800-615D7247-B4A4-4905-9433-75D62049F8C2Q33793856-8FAC27E5-6553-4522-9D28-EF95F5840DEFQ33958913-367B355E-FF91-4E05-88D2-078D1869466AQ33966144-87B80388-7F17-46DC-A7DE-99F1F84C3D41Q34020793-AE41C105-5CF5-4473-B334-8E4BCA743B71Q34137317-87BE6DEB-77DF-4EEA-9241-10543B91087CQ34147824-9218E3A3-E451-4217-8BC4-F6964DE8BAFBQ34318054-7F8B2BC5-99CE-4B59-B20A-45348447D8F8Q34405052-0CD0ED7E-1EF2-4A75-870F-5DC6F8862FEFQ34645099-8EB4975A-6EE3-48B7-A350-9177B9AF9D47Q34992307-59B7E8F9-5715-4EE6-8E76-97C91BB45B33Q35152909-DF2DD24F-0840-4981-BE09-4252BD35F772Q35230386-94C9F6BB-3AD9-42D5-92DE-999825A326ECQ35851399-E275B7B2-CD91-4769-A389-A332E298E559Q36501694-3642885D-1F21-4C54-A513-4EB4DB7EC01EQ36780789-0F9E93C2-0791-4F3F-BFB9-36A6F9DE41D1Q36842536-139EAC4F-4E66-40B1-923D-79881FCE6CA8Q36891378-123F43C3-3121-48BE-AD73-406487714623Q37067220-1DB74BD5-9B39-49E2-925C-2E6FCB20BC06Q37312523-9EFF868C-A087-4C66-BF9D-ECC3D2EDFB81Q37557630-5DC8C300-C808-4706-A73D-207CEA4A41FAQ37684037-BC98BF8B-1C3F-4057-841B-CBEB59BC9505Q37687406-14F5DE08-0D18-4114-B9A7-F9FCC97FA67BQ37721450-5AEB3013-B613-4FB6-9EFF-099737C70661Q37777093-4FE23661-EFB6-4728-A27B-43D49FFB1B78Q38005227-FAC5362D-5E7A-429C-873B-93D1B1D78CC0Q38005938-DDEFAFFB-6AE3-4848-8B12-7F2ABAB7050EQ38074105-EB93F2B3-5F9A-4DA8-9E00-CF3D5142B89EQ38207596-8301818B-42B6-44BD-AD12-BD6259E78765Q38951492-F1B92C9B-905C-465E-A1A8-903BDB8D6550Q38982831-307742B4-BBCF-4A57-BEC4-654C5BCA0C8AQ39175241-CE3B4364-16A1-4DAB-ADC7-DCC9CCAA0A90Q39540701-D8408C1F-1258-4559-BEFA-B61C9BFDA94A
P2860
Therapeutic potential of genetically modified mesenchymal stem cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic potential of genetically modified mesenchymal stem cells.
@en
Therapeutic potential of genetically modified mesenchymal stem cells.
@nl
type
label
Therapeutic potential of genetically modified mesenchymal stem cells.
@en
Therapeutic potential of genetically modified mesenchymal stem cells.
@nl
prefLabel
Therapeutic potential of genetically modified mesenchymal stem cells.
@en
Therapeutic potential of genetically modified mesenchymal stem cells.
@nl
P2093
P2860
P356
P1433
P1476
Therapeutic potential of genetically modified mesenchymal stem cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2008.35
P577
2008-03-20T00:00:00Z